Search research articles
Contact Us
Filters
Showing results (91-100 of 116) with videos related to
Page
of 12
Sort By:
Biochemical and Biophysical Research Communications
|
April 17, 2008
ABD56 causes osteoclast apoptosis by inhibiting the NFkappaB and ERK pathways
Aymen I Idris, Aymen Idris, Emanuela Mrak, et al.
Integrated Environmental Assessment and Management
|
February 11, 2025
Marine spatial planning as a potential practical approach to manage setiu wetland as an ecologically sensitive area
W Y Lua, N Aziz, I Idris, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 22, 2017
Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control
U Anyanwagu, H Olaoye, P Jennings, et al.
British Journal of Pharmacology
|
September 30, 2011
Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo
J Frantzias, J G Logan, P Mollat, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 10, 2004
Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitors
Rob J Van 't Hof, Aymen I Idris, Susan A Ridge, et al.
Calcified Tissue International
|
April 15, 2020
JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice
Silvia Marino, Giovana Carrasco, Boya Li, et al.
Scientific Reports
|
January 10, 2018
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis
Prabha Peramuhendige, Silvia Marino, Ryan T Bishop, et al.
Cell Metabolism
|
August 7, 2009
Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells
Aymen I Idris, Antonia Sophocleous, Euphemie Landao-Bassonga, et al.
Pigment Cell & Melanoma Research
|
July 12, 2020
Topical RT1640 treatment effectively reverses gray hair and stem cell loss in a mouse model of radiation-induced canities
Zoya T Anderson, Joseph W Palmer, Misgana I Idris, et al.
Nature Medicine
|
May 24, 2005
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
Aymen I Idris, Robert J van 't Hof, Iain R Greig, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 116) with videos related to
Sort By:
Page
of 12
Biochemical and Biophysical Research Communications
|
April 17, 2008
ABD56 causes osteoclast apoptosis by inhibiting the NFkappaB and ERK pathways
Aymen I Idris, Aymen Idris, Emanuela Mrak, et al.
Integrated Environmental Assessment and Management
|
February 11, 2025
Marine spatial planning as a potential practical approach to manage setiu wetland as an ecologically sensitive area
W Y Lua, N Aziz, I Idris, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 22, 2017
Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control
U Anyanwagu, H Olaoye, P Jennings, et al.
British Journal of Pharmacology
|
September 30, 2011
Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo
J Frantzias, J G Logan, P Mollat, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 10, 2004
Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitors
Rob J Van 't Hof, Aymen I Idris, Susan A Ridge, et al.
Calcified Tissue International
|
April 15, 2020
JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice
Silvia Marino, Giovana Carrasco, Boya Li, et al.
Scientific Reports
|
January 10, 2018
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis
Prabha Peramuhendige, Silvia Marino, Ryan T Bishop, et al.
Cell Metabolism
|
August 7, 2009
Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells
Aymen I Idris, Antonia Sophocleous, Euphemie Landao-Bassonga, et al.
Pigment Cell & Melanoma Research
|
July 12, 2020
Topical RT1640 treatment effectively reverses gray hair and stem cell loss in a mouse model of radiation-induced canities
Zoya T Anderson, Joseph W Palmer, Misgana I Idris, et al.
Nature Medicine
|
May 24, 2005
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
Aymen I Idris, Robert J van 't Hof, Iain R Greig, et al.
Page
of 12